Catalent (CTLT) Lowers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Catalent (CTLT) declines again after cutting guidance
May 19, 2023 8:15 AM EDTShares of drug manufacturer Catalent (NYSE: CTLT) declined Friday morning after telling investors it will provide a business update today instead of a normal review of its third quarter results. This was the third time Catalent delayed the earnings release, once again citing problems with accounting adjustments.
Catalent... More
Catalent (CTLT) to Hold Business Update Call Related to Delay of Third Quarter 2023 Results and Receives NYSE Notice Regarding Late Form 10-Q Filing
May 19, 2023 7:02 AM EDTCatalent, Inc. (Catalent or the Company) (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that, in light of the circumstances described in the Companys Notification of Late Filing on Form 12b-25 filed on May 11, 2023 (the Form 12b-25) with the Securities and Exchange Commission (the SEC); the Companys ongoing focus on finalizing its financial statements and other disclosures in its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023 (the Form 10-Q); and completing its quarterly closing processes and procedures, it requires additional time to... More
